Abraham Van Wyk

Abraham Van Wyk Email and Phone Number

Venture Investor | Technology | Start-up | Life Science Executive @ FHI Clinical Inc.
durham, north carolina, united states
Abraham Van Wyk's Location
City of Cape Town, Western Cape, South Africa, South Africa
Abraham Van Wyk's Contact Details

Abraham Van Wyk work email

Abraham Van Wyk personal email

n/a
About Abraham Van Wyk

Passionate about learning & innovation and excited about entrepreneurs brave enough to venture. My experience in life sciences has caused me to gravitate towards opportunities and individuals with exciting visions and clear strategies. I have had the privilege of being involved in R&D in search of solutions for the most daunting challenges, my aim is to maximize learning, and optimize transferring that. Balancing life between operational leadership and early stage investment ensures that from an investment partner we add value beyond financing and aim to allow start-up businesses to continue with their lean and simplified processes. People, partnership and synergy is the why. I am excited about all new ventures and opportunities. I hold a Bachelors of Science In Medical Sciences and a Bachelors of Science in Cellular Biology from the University of Pretoria and a MBA from the University of South Africa.

Abraham Van Wyk's Current Company Details
FHI Clinical Inc.

Fhi Clinical Inc.

View
Venture Investor | Technology | Start-up | Life Science Executive
durham, north carolina, united states
Website:
fhiclinical.com
Employees:
93
Abraham Van Wyk Work Experience Details
  • Fhi Clinical Inc.
    Chief Financial Officer
    Fhi Clinical Inc. Aug 2023 - Present
    Cape Town, Western Cape, South Africa
  • Fhi Clinical Inc.
    Managing Director
    Fhi Clinical Inc. Feb 2022 - Present
    Cape Town, Western Cape, South Africa
    FHI Clinical is a full-service contract research organization (CRO) with the global expertise, responsive approaches and proven solutions to manage complex clinical research around the world. Benefitting from our 50+ year history of clinical research, our team of approximately 450 global staff has worked on studies in nearly 75 countries. As problem solvers, forward thinkers and on-the-ground members of those communities, we’re dedicated to helping you find solutions to the research challenges that have kept life-saving medicines from at-risk populations. Visit fhiclinical.com or contact us at info@fhiclinical.com or 919.321.3321 to learn how we can put our diverse clinical and operational expertise to work for you.
  • Metanoia Bio Inc
    Co-Founder And Director
    Metanoia Bio Inc Jul 2020 - Present
    Los Angeles County, California, United States
  • Acquipharma
    General Partner
    Acquipharma Jan 2014 - Present
    South Africa
    Acquipharma is a boutique investment firm, Acquipharma invests and partners broadly with healthcare companies with interest in in Biotech, Medical Devices, Medical Technologies and Medical Services companies.
  • Troy Gold
    Director
    Troy Gold Mar 2018 - Present
    South Africa
    https://www.troygold.app/
  • Bugworks Research Inc.
    Investor And Board Observer
    Bugworks Research Inc. Aug 2018 - Present
    BUGWORKS is a drug discovery company that aims to discover novel pharmaceutical assets for combating Antimicrobial Resistance (AMR)
  • Bugworks Research Inc.
    Partner
    Bugworks Research Inc. May 2017 - Present
    Bangalore, India
    BUGWORKS (www.bugworksresearch.com) is a super exciting start-up drug discovery company, that aims to discover novel treatment options for resistant bacterial infections, and is a spin-off from Cellworks. Bugworks uses highly differentiated Systems Biology approaches to identify novel molecules and resurrect existing antibiotics that have failed owing to Drug Resistance. World class Anti-Infection team, using disruptive approaches in solving a huge Global problem. 100's of thousands of people are dying all over the world owing to infections that are inadequately addressed with today's antibiotics. Our hope is to unleash powerful yet safe drugs that can be used for tackle dangerous super-bugs!
  • Nuvoteq.Io
    Co-Founder And Board Member
    Nuvoteq.Io Jan 2015 - Present
    South Africa
    Leading a company who has established a network of proficient Software Developers, Clinical Research Experts, Computer System Validation (CSV) specialists and CFR part 11 experts whose technical skills are needed to design all or part of a solid clinical trial. Our uniquely designed solutions allow all the stakeholders within a specialised industry to work on a central, secure, cloud-hosted platform sharing the same database. The entire portal is governed using role-based access and has been implemented and built with the FDA's CFR Part 11 & EMA's Annexure 11 regulations and HIPAA privacy laws as the foundation. https://www.nuvoteq.ioPreviously TCD eClinical Solutions
  • Burl Concepts, Inc.
    Partner
    Burl Concepts, Inc. Oct 2014 - Present
    Greater San Diego Area
    BURL Concepts (www.burlconcept.com) is developing the BURL Device, a portable, battery-powered ultrasound device designed for the non-invasive, transcranial diagnosis of strokes ‘In The Field’. Using disposable ultrasound transducers it works in combination with ultrasound microbubbles. Acoustic response analytic algorithms have been developed to detect, analyze and interpret acoustic signals derived from microbubbles. Based on acoustic pattern recognition the analytic approach allows to detect large blood perfusion deficits in comparison between right / left brain hemisphere and to differentiate between underlying hemorrhagic or ischemic events as a cause for the stroke. The BURL Device carries wireless technology for real-time data transfer to a dedicated location. BURL Concepts is part of the BFT Equity Partners portfolio of companies.
  • Gri Bio, Inc.
    Board Member
    Gri Bio, Inc. Jan 2014 - Apr 2023
    Greater San Diego Area
    GRI Bio (NASDAQ: GRI) is a clinical-stage biopharmaceutical company focused on fundamentally changing the way inflammatory, fibrotic and autoimmune diseases are treated. GRI’s therapies are designed to target the activity of NKT cells, which are key regulators earlier in the inflammatory cascade, to interrupt disease progression and restore the immune system to homeostasis.
  • Tcd Outcomes Research
    Board Member
    Tcd Outcomes Research Nov 2015 - Feb 2022
    Johannesburg Area, South Africa
    TCD Outcomes Research (TCD OR) specialises in late phase health outcomes research by studying the real-world value of healthcare solutions and its economic and financial impact. www.tcd-global.com
  • Cytespace Research Private Limited
    Board Member
    Cytespace Research Private Limited Sep 2012 - Feb 2022
    Pretoria Area, South Africa
  • Triclinium Clinical Development
    Ceo
    Triclinium Clinical Development Nov 2015 - Jan 2022
    South Africa
    TCD is a publicly owned Contract Research Organization based in South Africa. TCD is a emerging markets focussed CRO, with a strong history in drug and device development in Diseases of Neglect as well as vaccine development. www.tcd-global.com
  • Clinical Information Solutions
    Co-Founder
    Clinical Information Solutions Jul 2012 - Dec 2014
    South Africa
  • Quintiles
    Associate Director, Region Head
    Quintiles Mar 2007 - Aug 2012
    Africa
  • Medical University Of South Africa, Medunsa
    Lecturer
    Medical University Of South Africa, Medunsa Jan 2006 - Jan 2007

Abraham Van Wyk Skills

Clinical Research Cro Ctms Pharmaceutical Industry Clinical Trials Clinical Development Gcp Regulatory Submissions Pharmacovigilance Drug Development Protocol Edc Management Clinical Monitoring Oncology Regulatory Affairs Infectious Diseases Regulatory Requirements Biotechnology Project Management Ich Gcp Cross Functional Team Leadership Business Development Operations Management Biopharmaceuticals Vaccines Clinical Data Management Clinical Site Management Leadership Fda Diabetes Therapeutic Areas Pharmaceutics It Solutions Medical Writing Sop Operational Risk Management Crfs Clinical Operations Lifesciences Cross Cultural Budgets

Abraham Van Wyk Education Details

Frequently Asked Questions about Abraham Van Wyk

What company does Abraham Van Wyk work for?

Abraham Van Wyk works for Fhi Clinical Inc.

What is Abraham Van Wyk's role at the current company?

Abraham Van Wyk's current role is Venture Investor | Technology | Start-up | Life Science Executive.

What is Abraham Van Wyk's email address?

Abraham Van Wyk's email address is ab****@****les.com

What schools did Abraham Van Wyk attend?

Abraham Van Wyk attended University Of Pretoria/universiteit Van Pretoria, University Of Pretoria/universiteit Van Pretoria, University Of South Africa/universiteit Van Suid-Afrika.

What skills is Abraham Van Wyk known for?

Abraham Van Wyk has skills like Clinical Research, Cro, Ctms, Pharmaceutical Industry, Clinical Trials, Clinical Development, Gcp, Regulatory Submissions, Pharmacovigilance, Drug Development, Protocol, Edc.

Who are Abraham Van Wyk's colleagues?

Abraham Van Wyk's colleagues are Kennedy Kapinga, Dr. Azad M Abul Kalam, Lehlogonolo Malesa, Zen Hafy, Maureen Mareverwa, Josh Vinson, Carmen Lester.

Not the Abraham Van Wyk you were looking for?

  • Abraham van Wyk

    Braam
    Pretoria
    1
    gmail.com
  • Abraham Van Wyk

    Experienced Accountant & Financial Manager, Business Developer / Consultant, Sox Consultant, Granite Mining Financial Consultant, Motor Trade Financial Manager, Agricultural Seed Merchant Financial Manager, Auditor
    Krugersdorp
  • Abraham van Wyk

    Cloud Intrastructure And Security Specialist
    Western Cape, South Africa
  • Abraham E. van Wyk

    Civil Engineer| Innovator| Phd Candidate
    Stellenbosch

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.